192 related articles for article (PubMed ID: 32659427)
1. DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents.
Ma Y; Chai N; Jiang Q; Chang Z; Chai Y; Li X; Sun H; Hou J; Linghu E
Pharmacol Res; 2020 Oct; 160():105071. PubMed ID: 32659427
[TBL] [Abstract][Full Text] [Related]
2. A novel small-molecule antagonist enhances the sensitivity of osteosarcoma to cabozantinib in vitro and in vivo by targeting DNMT-1 correlated with disease severity in human patients.
Wang JH; Zeng Z; Sun J; Chen Y; Gao X
Pharmacol Res; 2021 Nov; 173():105869. PubMed ID: 34481973
[TBL] [Abstract][Full Text] [Related]
3. 3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.
Peng X; Chang H; Chen J; Zhang Q; Yu X; Mi M
BMC Cancer; 2017 Sep; 17(1):619. PubMed ID: 28870206
[TBL] [Abstract][Full Text] [Related]
4. MiR-377 reverses cancerous phenotypes of pancreatic cells via suppressing DNMT1 and demethylating tumor suppressor genes.
Azizi M; Fard-Esfahani P; Mahmoodzadeh H; Fazeli MS; Azadmanesh K; Zeinali S; Teimoori-Toolabi L
Epigenomics; 2017 Aug; 9(8):1059-1075. PubMed ID: 28758420
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-34a Alleviates Gemcitabine Resistance in Pancreatic Cancer by Repression of Cancer Stem Cell Renewal.
Pan Y; Li K; Tao X; Zhao Y; Chen Q; Li N; Liu J; Go VLW; Guo J; Gao G; Xiao GG
Pancreas; 2021 Oct; 50(9):1260-1266. PubMed ID: 34860809
[TBL] [Abstract][Full Text] [Related]
6. Methylation of the miR‑29b‑3p promoter contributes to angiogenesis, invasion, and migration in pancreatic cancer.
Wang L; Mu N; Qu N
Oncol Rep; 2021 Jan; 45(1):65-72. PubMed ID: 33416135
[TBL] [Abstract][Full Text] [Related]
7. DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression.
Xie VK; Li Z; Yan Y; Jia Z; Zuo X; Ju Z; Wang J; Du J; Xie D; Xie K; Wei D
Clin Cancer Res; 2017 Sep; 23(18):5585-5597. PubMed ID: 28659310
[No Abstract] [Full Text] [Related]
8. The interaction between miR‑148a and DNMT1 suppresses cell migration and invasion by reactivating tumor suppressor genes in pancreatic cancer.
Hong L; Sun G; Peng L; Tu Y; Wan Z; Xiong H; Li Y; Xiao W
Oncol Rep; 2018 Nov; 40(5):2916-2925. PubMed ID: 30226601
[TBL] [Abstract][Full Text] [Related]
9. 3,6-Dihydroxyflavone Suppresses Breast Carcinogenesis by Epigenetically Regulating miR-34a and miR-21.
Peng X; Chang H; Gu Y; Chen J; Yi L; Xie Q; Zhu J; Zhang Q; Mi M
Cancer Prev Res (Phila); 2015 Jun; 8(6):509-17. PubMed ID: 25784176
[TBL] [Abstract][Full Text] [Related]
10. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells.
Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X
Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.
Kwon H; Song K; Han C; Zhang J; Lu L; Chen W; Wu T
Am J Pathol; 2017 Oct; 187(10):2288-2299. PubMed ID: 28923203
[TBL] [Abstract][Full Text] [Related]
12. Overexpressing microRNA-34a overcomes ABCG2-mediated drug resistance to 5-FU in side population cells from colon cancer via suppressing DLL1.
Xie ZY; Wang FF; Xiao ZH; Liu SF; Tang SL; Lai YL
J Biochem; 2020 Jun; 167(6):557-564. PubMed ID: 32044957
[TBL] [Abstract][Full Text] [Related]
13. ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells.
Si X; Liu Y; Lv J; Ding H; Zhang XA; Shao L; Yang N; Cheng H; Sun L; Zhu D; Yang Y; Li A; Han X; Sun Y
Oncotarget; 2016 Apr; 7(15):20966-80. PubMed ID: 26980709
[TBL] [Abstract][Full Text] [Related]
14. DNMT3B silencing suppresses migration and invasion by epigenetically promoting miR-34a in bladder cancer.
Xu K; Chen B; Li B; Li C; Zhang Y; Jiang N; Lang B
Aging (Albany NY); 2020 Nov; 12(23):23668-23683. PubMed ID: 33221743
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy.
Li H; Yu G; Shi R; Lang B; Chen X; Xia D; Xiao H; Guo X; Guan W; Ye Z; Xiao W; Xu H
Mol Cancer; 2014 Jan; 13():8. PubMed ID: 24423412
[TBL] [Abstract][Full Text] [Related]
16. The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy.
Zhan Q; Fang Y; Deng X; Chen H; Jin J; Lu X; Peng C; Li H; Shen B
Cancer Invest; 2015; 33(7):267-75. PubMed ID: 25950085
[TBL] [Abstract][Full Text] [Related]
17. DNMT1 and EZH2 mediated methylation silences the microRNA-200b/a/429 gene and promotes tumor progression.
Ning X; Shi Z; Liu X; Zhang A; Han L; Jiang K; Kang C; Zhang Q
Cancer Lett; 2015 Apr; 359(2):198-205. PubMed ID: 25595591
[TBL] [Abstract][Full Text] [Related]
18. EZH2 coupled with HOTAIR to silence MicroRNA-34a by the induction of heterochromatin formation in human pancreatic ductal adenocarcinoma.
Li CH; Xiao Z; Tong JH; To KF; Fang X; Cheng AS; Chen Y
Int J Cancer; 2017 Jan; 140(1):120-129. PubMed ID: 27594424
[TBL] [Abstract][Full Text] [Related]
19. DNMT1 as a therapeutic target in pancreatic cancer: mechanisms and clinical implications.
Wong KK
Cell Oncol (Dordr); 2020 Oct; 43(5):779-792. PubMed ID: 32504382
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
